VJHemOnc is committed to improving our service to you

ASH 2019 | Comparison of ZUMA-1 and SCHOLAR-1 outcomes

VJHemOnc is committed to improving our service to you

Sattva Neelapu

Sattva Neelapu, MD Anderson Cancer Center, Houston, TX, details a comparison of the 2-year outcomes in the ZUMA-1 and SCHOLAR-1 studies. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter